Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
AssigneeImmunocept, L.L.C.
InventorsJames R. Matson, Patrice A. Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunocept, L.L.C.
InventorsJames R. Matson, Patrice A. Lee
Estimating the term…
A hemofiltration system for a mammal is provided with a hemofilter and an adsorbent device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorbent device has one or more adsorbent materials and is used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter removing inflammatory mediators that cause inflammatory mediator related disease, sepsis, and SIRS/MODS/MOSF to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream is selectively combined with the filtered blood stream and together with the filtered blood stream is returned to the mammal.
A method for treating inflammatory mediator related diseases including sepsis, septic shock, systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising:
A hemofiltration system to treat an inflammatory mediator related disease in a mammal, comprising:
A method for treating inflammatory mediator related disease including sepsis, septic shock, and inflammatory mediator-related diseases such as systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising;
A hemofiltration system to treat an inflammatory mediator related disease including sepsis and septic shock in a mammal, comprising:
A hemofiltration system to treat an inflammatory mediator related disease including sepsis and septic shock in a mammal comprising:
A hemofiltration system to treat an inflammatory mediator related disease including sepsis and septic shock in a mammal, comprising:
A hemofiltration system to treat an inflammatory mediator related disease including sepsis and septic shock in a mammal comprising:
A method for treating inflammatory mediator related diseases including sepsis, septic shock, systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising;
A hemofiltration system to treat an inflammatory mediator related disease in a mammal, comprising:
A method for treating inflammatory mediator related disease including sepsis, septic shock, and inflammatory mediator-related diseases such as systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising;
A method for treating inflammatory mediator related diseases including sepsis, septic shock, systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising:
A method for treating inflammatory meidator related disease including sepsis, septic shock, systemic inflammatory response syndrome, multiple organ system dysfunction syndrome, and multiple organ system failure in a mammal comprising:
Dependencies are inferred from the claim text.